Candidiasis, Oral
28
0
0
24
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.6%
1 terminated out of 28 trials
96.0%
+9.5% vs benchmark
32%
9 trials in Phase 3/4
0%
0 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (28)
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
CelAgace™ OraRinse Solution for Treatment of Candidiasis
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
Effect of Oral Hygienization in Newborn on Candida Spp Colonization
Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species
Relationship Between Oral Hygiene in Newborns and Candida Spp.
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis
Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection
A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2
A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole